June 23, 2026

Clinical Oncology Education

A New Dawn for Pancreatic Cancer: Daraxonrasib Nearly Doubles Survival in Landmark Phase 3 Trial a-new-dawn-for-pancreatic-cancer-daraxonrasib-nearly-doubles-survival-in-landmark-phase-3-trial

A New Dawn for Pancreatic Cancer: Daraxonrasib Nearly Doubles Survival in Landmark Phase 3 Trial

Azzam Bilal Chamdy June 1, 2026 0
In a development being hailed by the oncology community as a potential "landscape-changing" breakthrough, results from the...
Read More Read more about A New Dawn for Pancreatic Cancer: Daraxonrasib Nearly Doubles Survival in Landmark Phase 3 Trial
New Hope for High-Risk Lymphoma: Phase III frontMIND Trial Challenges Decades-Old Standard of Care new-hope-for-high-risk-lymphoma-phase-iii-frontmind-trial-challenges-decades-old-standard-of-care

New Hope for High-Risk Lymphoma: Phase III frontMIND Trial Challenges Decades-Old Standard of Care

Muslim May 31, 2026 0
In a breakthrough that promises to reshape the therapeutic landscape for aggressive non-Hodgkin lymphomas, researchers have unveiled...
Read More Read more about New Hope for High-Risk Lymphoma: Phase III frontMIND Trial Challenges Decades-Old Standard of Care
Could Short-Term Fasting Improve Chemotherapy Outcomes in Ovarian Cancer? New Research Suggests Potential could-short-term-fasting-improve-chemotherapy-outcomes-in-ovarian-cancer-new-research-suggests-potential

Could Short-Term Fasting Improve Chemotherapy Outcomes in Ovarian Cancer? New Research Suggests Potential

Nila Kartika Wati May 30, 2026 0
A promising new pilot study from Italy, set to be presented at the 2026 American Society of...
Read More Read more about Could Short-Term Fasting Improve Chemotherapy Outcomes in Ovarian Cancer? New Research Suggests Potential
Landmark Oncology Breakthrough: GLP-1 Agonists Linked to Reduced Metastatic Risk in Obesity-Related Cancers landmark-oncology-breakthrough-glp-1-agonists-linked-to-reduced-metastatic-risk-in-obesity-related-cancers

Landmark Oncology Breakthrough: GLP-1 Agonists Linked to Reduced Metastatic Risk in Obesity-Related Cancers

Azzam Bilal Chamdy May 30, 2026 0
As the global oncology community turns its collective attention toward Chicago for the 2024 American Society of...
Read More Read more about Landmark Oncology Breakthrough: GLP-1 Agonists Linked to Reduced Metastatic Risk in Obesity-Related Cancers
Advancing Precision Oncology: Taylor & Francis Announces New Article Collection on Breast Cancer Biomarkers advancing-precision-oncology-taylor-francis-announces-new-article-collection-on-breast-cancer-biomarkers-1

Advancing Precision Oncology: Taylor & Francis Announces New Article Collection on Breast Cancer Biomarkers

Rifan Muazin May 29, 2026 0
The landscape of breast cancer treatment is currently undergoing a paradigm shift, moving away from "one-size-fits-all" chemotherapy...
Read More Read more about Advancing Precision Oncology: Taylor & Francis Announces New Article Collection on Breast Cancer Biomarkers

You may have missed

unnamed-file-11

Pevita Pearce June 23, 2026
the-genetic-architects-how-modern-plant-transformation-is-reshaping-our-world

The Genetic Architects: How Modern Plant Transformation is Reshaping Our World

Evan Lee Salim June 23, 2026
the-borderless-pharma-frontier-architecting-intellectual-property-in-a-globalized-rd-ecosystem

The Borderless Pharma Frontier: Architecting Intellectual Property in a Globalized R&D Ecosystem

Neng Nana June 23, 2026
myth-vs-medicine-experts-from-the-breast-cancer-research-foundation-tackle-modern-misinformation

Myth vs. Medicine: Experts From the Breast Cancer Research Foundation Tackle Modern Misinformation

Layla Zulfa June 23, 2026